May 27, 2026
1 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
The medications most likely to cause thyroid eye disease are alemtuzumab, certain immune checkpoint inhibitors, amiodarone and lenalidomide, according to a review in Graefe’s Archive for Clinical and Experimental Ophthalmology. “Medication-associated TED is an important diagnostic consideration in orbital inflammatory disease,” Terence Ang, PhD, of University of Adelaide, Australia, and
May 27, 2026
1 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

Veligrotug labeling shows data for both the active and chronic forms of TED

PHOENIX — Mirvetuximab, an antibody drug conjugate for the treatment of certain types of cancer, can lead to adverse ocular…

From puffy eyes to vision changes, here are some of the most common symptoms that may point to thyroid issues. | Health

The FDA approved Lumvoa, a full insulin-like growth factor 1 receptor antagonist, for the treatment of thyroid eye disease,…

Find the latest Regulatory and Legislative Optometry news articles, videos, podcasts, and meeting coverage from medical experts…

Viridian Therapeutics Announces U.S. FDA Approval and Launch of Lumvoa™ (veligrotug-vvze) for the Treatment of Thyroid Eye Disease